期刊文献+

肝癌组织中PTEN和TIMP-3的表达及其临床意义 被引量:5

Expression of PTEN and TIMP-3 in hepatocellular carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨抑癌基因PTEN和TIMP-3在肝细胞性肝癌(HCC)组织中的表达及其临床意义。方法收集30例HCC、癌旁组织和10例正常肝组织,用qRT-PCR、Western blot、免疫组化SP法检测PTEN、TIMP-3mRNA和蛋白表达,分析PTEN和TIMP-3表达与HCC临床病理特征的关系。结果癌组织中PTEN和TIMP-3mRNA和蛋白表达均明显低于癌旁组织、正常肝组织(P<0.01),且在癌旁组织中的表达亦明显低于正常肝组织(P<0.01)。PTEN和TIMP-3蛋白表达在肝外转移、分化差、血清AFP≥400μg/L和Ⅲ~Ⅳ期肝癌组织中的表达明显低于无肝外转移、分化好、血清AFP<400μg/L和Ⅰ~Ⅱ期肝癌(P<0.01或0.05)者;两者在是否伴有肝硬化和不同肿瘤大小肝癌组织中的表达均无统计学意义(P>0.05)。结论 HCC癌组织中PTEN和TIMP-3表达下调,表达水平有助于判断HCC侵袭转移能力、临床分期和肝外转移。 Objective To investigate the expression of PTEN and TIMP-3 in hepatocellular carcinoma (HCC) and its clinical significance. Methods Expression of PTEN and TIMP-3 mRNA and protein in tumor and adjacent tissue of 30 HCC cases and 10 cases of normal liver tissue was detected by qRT-PCR, Western blot and immunohistochemical SP method, respectively. The correlation between expression of PTEN and TIMP-3 and clinicopathologic features in HCC was analyzed. Results The expression of PTEN and TIMP-3 mRNA and protein in tumor and adjacent tissue of HCC was significantly lower than that in the normal liver tissue (P〈0.01), especially in tumor tissue (P〈0.01). The expression of PTEN and TIMP-3 protein was related to the metastasis of HCC, tumor differentiation, serum alpha-fetoprotein level (AFP≥400 μg/L) and TNM staging (P〈0.01 or 0.05), but unrelated to the tumor size and hepatocirrhosis (P〉0.05). Conclusion There is a downexpression of PTEN and TIMP-3 in HCC. The expression PTEN and TIMP-3 may be helpful for evaluating the invasiveness, metastasis, clinical staging and extrahepatic metastasis of HCC.
出处 《广东医学院学报》 2012年第4期371-374,共4页 Journal of Guangdong Medical College
关键词 肝细胞性肝癌 PTEN TIMP-3 hepatocellular carcinoma; PTEN; TIMP-3
  • 相关文献

参考文献3

二级参考文献29

  • 1Bing-HuiLi PengZhao Shi-ZhengLiu Yue-MingYu MeiHan Jin-KunWen.Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis[J].World Journal of Gastroenterology,2005,11(20):3046-3050. 被引量:21
  • 2王小亚 吴志全.免疫组化的理论和技术[A].纪小龙施作霖.诊断免疫组化[C].北京:军事医学科学出版社,1997.12-25.
  • 3萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T.分子克隆实验指南[M]:第2版[M].北京:科学出版社,1997.363-370.
  • 4Resheed B K,Stenzel T T,Mclendon R E,et al.PTEN gene mutations are seen in high-grade but not in lowgrade gliomas.Cancer Res,1997,57(19):4187-4190.
  • 5Gu J,Tamura M,Yamaola K M.Tumor suppressor PTEN inhibits integrin and growth factor-mediated mitogen-activated protein (MAP)kinase signaling pathways[J].J Celll Biol,1998,143:1375-1483.
  • 6Komazawa N,Suzuki A,Sano S,et al.Tumorigenesis facilitated by Pten deficiency in the skin:Evidence of p53-Pten complex formation on the initiation phase[J].Cancer Sci,2004,95 (8):639-643.
  • 7Sun H,Leshe R,LI D M,et al.PTEN modulates cell cicle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathwayproc[J].Natl Acad sci U S A,1999,96(11):6199-204.
  • 8Panigrahi A,Pinder S,Chan S,et al.The role of PTEN and its signalling pathways,including AKT,in breast eancer; an assessment of relationships with other prognostic factors and with outcome[J].J Pathol,2004,204 (1):93-100.
  • 9Mao J H,To M D,Perez-Losada J,et al.Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression[J].Genes Dev,2004,18(15):1800-1805.
  • 10Staack A,Badendieck S,Schnorr D,Loening SA,Jung K.Combined determination of plasma MMP2,MMP9,and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladderBMC Urology,2006.

共引文献15

同被引文献53

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部